ClearLight Biotechnologies, Inc.
ClearLight Biotechnologies provides contract research and development services to pharmaceutical companies who seek to improve the efficacy of potential drug candidates. The company provides pharmaceutical, biotechnology, and academic researchers with CLARITY Tissue Clearing, 3D immunostaining, and Tru3D image analysis services. The company is developing an automated instrumentation platform based on the CLARITY lipid-clearing technique developed by Dr. Deisseroth and colleagues at Stanford University. ClearLight empowers researchers to see more biology within the tissue microenvironment leading to improved diagnostic, prognostic, and predictive treatment of disease so we can all live healthier lives.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Nationally (across the country)
- Year Founded:
- 2015
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
Fast Facts
- Founded in 2015 by Karl Deisseroth MD, PhD
- Early stage private company backed by Wiegers and affiliates, Pivotal and KESA Partners
- Experts at CLARITY Tissue Processing, thick tissue antibody staining, and Tru3D tissue analysis
- Provides research use only lab services to pharmaceutical, biotechnology and academic researchers
- Developing next-generation tissue processing and image analysis platform to facilitate 3D analysis of preclinical and clinical models of disease
Building a Collaborative Future
ClearLight Biotechnologies (formerly ClearLight Diagnostics, LLC) was founded in 2015 by Karl Deisseroth MD, PhD, the inventor of CLARITY, Optogenetics, and STARmap technologies. It is an early stage company focused on developing automated instrumentation and associated reagents to simplify and expedite non-destructive 3D tissue analysis to facilitate preclinical and clinical research applications. The platform will enable an end-to-end solution for 3D analysis of preclinical and clinical models of disease.
Enter the MicroEnvironment
- Imagine non-destructive tissue processing and digital spatial image analysis in 3D to facilitate your pre-clinical and clinical research studies
- Imagine a way to illuminate your tissue microenvironment in a 3D volume
- Imagine automating this process and integrating it into your normal tissue processing work flow